Network meta-analysis ranks EoE treatments by efficacy, safety
A systematic review and network meta-analysis of 48 randomized controlled trials (3,963 participants) compared pharmacologic, dietary, and mechanical treatments for eosinophilic esophagitis. High-frequency dupilumab and swallowed topical corticosteroids showed the largest improvements in symptoms and quality of life, while certain biologics and epicutaneous immunotherapy were not different from placebo for symptoms; four- and six-food elimination diets showed modest, low-certainty symptom benefit over one-food elimination with greater burden. The authors note that histologic improvement did not guarantee improvement in patient-important outcomes.
Most relevant for: Clinicians managing children and adults with eosinophilic esophagitis who are choosing among pharmacologic, dietary, or mechanical treatment options.
Read the original at Journal of Allergy and Clinical ImmunologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More allergy & immunology updates
- Network meta-analysis compares antihistamines and adjuncts for chronic urticariaOct 16, 2026
- Allergic-like reactions to mRNA vaccines occurred only in high-risk groupOct 13, 2026
- Oral deucrictibant speeds symptom relief in HAE attacks, trial findsOct 8, 2026
- PGE2 signaling found to modulate MRGPRX2-mediated anaphylaxis severitySep 30, 2026
- Registry data compare rapamycin and leniolisib in APDSSep 28, 2026